Assessment of Imaging Findings of Renal Carcinoma Subtypes with 3.0T MRI

Niger J Clin Pract. 2023 Nov 1;26(11):1750-1757. doi: 10.4103/njcp.njcp_373_23. Epub 2023 Dec 4.

Abstract

Background: The prevalence of renal masses has escalated as a result of the augmented utilization of cross-sectional imaging techniques. The approach to managing renal masses may exhibit variability contingent upon the subtype of renal cell carcinoma (RCC).

Aim: This research aimed to distinguish between clear cell and papillary RCCs, utilizing dynamic contrast magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI).

Materials and methods: The study assessed the MR images of 112 patients with RCC. Two radiologists independently analyzed tumor size, vascular involvement, signal characteristics in T1- and T2-weighted sequences, the presence of hemosiderin, both microscopic and macroscopic fat content, enhancement patterns, and apparent diffusion coefficient (ADC) values derived from b-values of 1000 s/mm².

Results: Seventy patients had clear cell RCC, and 42 had papillary. In the clear cell RCC, microscopic fat content was significantly higher than the papillary RCC (P < 0.001). However, in papillary RCC, hemosiderin content was substantially greater (P = 0.001). On T2-weighted MR images, clear cell RCCs were usually hyperintense, while papillary RCCs were hypointense (P < 0.001). Even though the rapid enhancement pattern was observed in clear cell RCCs, the progressive enhancement pattern was more prevalent in papillary RCCs (P < 0.001).

Conclusion: Hyperintensity on T2-weighted images, microscopic fat content, and rapid enhancement pattern may be indicative of clear cell RCC, whereas hypointensity on T2-weighted images, hemosiderin content, and a progressive contrast pattern may be diagnostic for papillary RCC.

MeSH terms

  • Carcinoma, Renal Cell* / pathology
  • Diagnosis, Differential
  • Diffusion Magnetic Resonance Imaging / methods
  • Hemosiderin
  • Humans
  • Kidney Neoplasms* / pathology
  • Magnetic Resonance Imaging / methods
  • Retrospective Studies

Substances

  • Hemosiderin